SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
IMNR - Immune Response
An SI Board Since April 1996
Posts SubjectMarks Bans Symbol
1510 20 0 IMNR
Emcee:  Nagaraju R. Arakotaram Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1135 David S --- Probably not or it would not have got this far along--- even if it Captain Jack-11/3/1998
1134 This is pretty much my opinion, too ... ever since I heard their Leedom analystJohn S. Baker-11/3/1998
1133 I look for $25+ by year end Emec-11/3/1998
1132 Could be a pipe bomb. David S.-11/3/1998
1131 MJ--- this one has too far to go to be looking at exit points now. Too many haCaptain Jack-11/2/1998
1130 John Rakoci Looks like the accumulation is translating to movement. How far MJ-11/2/1998
1129 A 13% price increase and triple volume=== I do not need hit between the eyes toCaptain Jack-11/2/1998
1128 Looks that way, doesn't it! JSb. John S. Baker-11/2/1998
1127 Me thinks something is up Emec-11/2/1998
1126 Earnings report out. See biz.yahoo.comBob Walsh-10/29/1998
1125 I think we are on the verge of greatness Emec-10/28/1998
1124 No doubt, David, that bio-tech *development* companies involve considerable risJohn S. Baker-10/27/1998
1123 Prudential reiterated their strong buy yesterday with a 12 month target of $27.Emec-10/27/1998
1122 Cyberken, IMNR is one company that will NEVER run out of cash. Their problem wiEmec-10/27/1998
1121 God! It's been so long I misspelled the company name. Put the $$ into ToproCYBERKEN-10/27/1998
1120 There is a 6 foot long model of the amylin molecule (whatever the hell it is caDavid S.-10/27/1998
1119 Don't mean to be a wet blanket here, but a lot of biotechs kick ass in PhasCYBERKEN-10/27/1998
1118 Phase 3 is in the near term plans Emec-10/26/1998
1117 I have no idea, but it would seem very strange to me to have an apparently-succJohn S. Baker-10/26/1998
1116 Are they planning a Phase III? How much of the cost will AGPH pick up? CYBERKEN-10/26/1998
1115 News: biz.yahoo.com Phase II complete on study using REMUNE with HAART in AIDJohn S. Baker-10/26/1998
1114 BRIAN THOMAS HERTZOG Thanks ever so much for the update on Van Kasper. So we hMJ-10/25/1998
1113 Oct 19, 1998 Van Kasper & Co (IMNR $12 13/16, Strong Buy) forthewise (M/MinBrian Thomas Hertzog-10/24/1998
1112 David S. I have always been accused of being too much in my head. So I can seMJ-10/16/1998
1111 David is that your alias? Are you really BILL CLINTON on the imnr thread. Waitnord-10/12/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News